Company Filing History:
Years Active: 2012-2018
Title: Christof Schulz: Innovator in Cell Culture Technology
Introduction
Christof Schulz is a notable inventor based in Ayer, MA (US), recognized for his contributions to the field of cell culture technology. With a total of 9 patents, he has made significant advancements in the production of recombinant proteins, particularly antibodies, in mammalian cell cultures.
Latest Patents
Among his latest patents, Schulz has developed a modified serum-free cell culture medium. This invention describes improved methods and compositions for producing recombinant proteins, such as antibodies, in mammalian cell culture. Additionally, it provides enhanced cell culture media, including production media, feed solutions, and combination feeds, aimed at improving protein productivity in mammalian cell culture. Another notable patent involves methods of producing adalimumab, which also focuses on improved methods and compositions for recombinant protein production in mammalian cell cultures.
Career Highlights
Throughout his career, Christof Schulz has worked with prominent companies in the biotechnology sector, including AbbVie Inc. and Abbott Laboratories Corporation. His experience in these organizations has contributed to his expertise in developing innovative solutions for cell culture processes.
Collaborations
Schulz has collaborated with several professionals in his field, including Itzcoatl A Pla and John C Fann. These collaborations have likely enriched his research and development efforts, leading to the successful creation of his patented technologies.
Conclusion
In summary, Christof Schulz is a distinguished inventor whose work in cell culture technology has led to significant advancements in the production of recombinant proteins. His innovative patents and collaborations reflect his commitment to improving biotechnological processes.